RetractedArticleThe Journal of clinical investigation2021

Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.

Hanchen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.